NCT03899142View on ClinicalTrials.gov

Pharmacokinetics of New HepBQuin

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 20, 2019

Primary Completion Date

July 4, 2019

Study Completion Date

July 4, 2019

Conditions
Healthy
Interventions
BIOLOGICAL

a human hepatitis B immunoglobulin solution for injection for intramuscular administration

intramuscular administration

Trial Locations (1)

Unknown

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Prothya Biosolutions

INDUSTRY